Company lists · Data refreshed September 2026
Top 20 Immunotherapy venture capital companies based in Australia
RevenueBase identified 32 immunotherapy venture capital companies headquartered in Australia as of September 2026 and tracks 400 professional contacts across them, including 191 with verified work emails and 59 with mobile numbers. Melbourne is the largest hub.
This list covers immunotherapy venture capital companies headquartered in Australia, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, how directly it supports the match, and when it was last checked. Data refreshed September 3, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase SmartSearch, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 20 largest immunotherapy venture capital companies based in Australia
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 50 | ||||
“Immutep is a late-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 2 | 37 | ||||
“Cartherics is a biotechnology company focused on developing innovative cancer therapies.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 3 | 34 | ||||
“Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 4 | Kazia Therapeutics LimitedIndirect evidence | 19 | |||
“Kazia Therapeutics Limited (NASDAQ: KZIA) is a clinical-stage oncology company focused on high-need cancers of the central nervous system and select aggressive solid tumors.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 5 | 18 | ||||
“Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 6 | 18 | ||||
“ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 7 | 15 | ||||
“Carina Biotech An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 8 | 10 | ||||
“Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 9 | 10 | ||||
“AdAlta (ASX:1AD) aims to become a leader in cell therapy for cancer, providing a pathway for innovative cellular immunotherapies for solid cancers originating in Asia, and China…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 10 | 9 | ||||
“Aculeus Therapeutics is a Biotech company based in Melbourne Australia, developing small molecule drugs that modulate the immune system for the treatment of cancer and other…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 11 | 9 | ||||
“Sementis Ltd is an Australian unlisted public biotechnology company based in Adelaide, South Australia and dedicated to research and development of new vaccines to tackle viruses…” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 12 | 9 | ||||
“Chimeric Therapeutics is the ASX leader in cell therapy.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 13 | 7 | ||||
“HaemaLogiX focus is the development and commercialisation of novel immuno-oncology and immune-therapies.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 14 | Kira Biotech PTY LTDIndirect evidence | 4 | |||
“Kira Biotech is an emerging Australian biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 15 | Lateral Pharma PTY LTDIndirect evidence | 4 | |||
“A New Frontier in Immunology & Inflammation.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 16 | 3 | ||||
“Immunosis is a startup company developing a diagnostic platform technology that can be used to diagnose patients with immune dysfunctions.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 17 | 3 | ||||
“Ascend is a cancer immunotherapy company developing medicines to treat primary, recurrent and metastatic cancers.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 18 | 2 | ||||
“Oncology One is focused on building a diversified small molecule oncology pipeline and aims to help translate more of Australia’s world-class cancer research into treatments.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 19 | Selvax PTY LTDIndirect evidence | 2 | |||
“Selvax is a preclinical stage company developing a safe, effective, immunological-based treatment for a range of hard to treat solid tumours.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 20 | Onko-Innate PTY LTDIndirect evidence | 1 | |||
“oNKo-innate is a leading innate immune drug discovery and development company located in Melbourne, Australia.” Source: company website · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
Showing 20 of 32 immunotherapy venture capital companies based in Australia
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 191 reachable decision-makers.
Free signup · no credit card
Immunotherapy venture capital companies based in Australia at a glance
As of Sep 3, 2026Companies by employee count
Verified emails by last verification
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and evidence rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase SmartSearch, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in Australia whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
- What we exclude
- Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside Australia are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and an evidence rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 191 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Frequently asked
How many immunotherapy venture capital companies are there based in Australia?
RevenueBase identified 32 immunotherapy venture capital companies headquartered in Australia as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Immutep Limited, headquartered in Sydney, tops this list with the largest team on record.
Which city has the most immunotherapy venture capital companies?
Melbourne leads with 12 headquartered companies, followed by Sydney (4) and Adelaide (3).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 191 verified decision-maker contacts tracked across these 32 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.
Ready to reach these companies? Verified emails and direct dials for all 32 immunotherapy venture capital companies based in Australia. Start with a free account, no credit card.
Get the full listRelated lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
- Immunotherapy venture capital companies based in San Francisco, United States
Browse the directory
Browse: Companies home · All Australia lists · All Immunotherapy venture capital companies lists · New lists
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase SmartSearch, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Germany
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland